The publisher, authors, editors, syndication partners, and all distribution platforms make no warranties or representations regarding the completeness, accuracy, or reliability of the information and expressly disclaim any and all liability for any losses, damages, or harm resulting from the use or misuse of any product referenced in this content
"2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society (in Eng)
It is typically reconstituted with 1ml of water for a 5mg/ml solution
This means cagrilintide could theoretically combine with tirzepatide for even greater effects, though clinical data for this combination remains limited
Evidence source : NEJM (2023 Phase 2), Novo Nordisk trials (NCT04982530)